Hearing Loss Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have tinnitus in both ears that has been diagnosed as long-term subjective tinnitus (the type where only the person affected can hear the sound).
- People who are male or female, aged between 18 and 60 years.
- People who are right-handed, able to follow the study requirements, and willing to sign a consent form.
- People who are not currently taking part in any other clinical trials.
Who may not be able to join:
- People whose tinnitus is classified as "objective" (the type that can be detected by someone else, such as a doctor).
- People who have nervous system or neuropsychiatric conditions that could significantly affect brain activity measurements taken during the study (confirm with trial site).
- People who have serious heart or blood vessel conditions, severe liver or kidney disease, or other major serious health conditions.
- People for whom acupuncture is not considered safe, for example those with a tendency to bleed easily.
- Women who are pregnant or breastfeeding.
- People who have received any treatment for tinnitus, whether medication or other therapies, within the past four weeks.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hantong Hu, M.D, The Third Affiliated hospital of Zhejiang Chinese Medical University
Phone: 18334334738
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in resting-state functional connectivity (RSFC); Change in hemoglobin signals; Change in Tinnitus Severity Grading
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.